Company / Cash & Equivalents
American Healthcare REIT, Inc. Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$114.8M
FY2025
5-year range
$76.7M / $114.8M
FY2021-FY2025
Trend
+49.7%
vs FY2024
Sector context
#70 of 133
Real Estate
What the data says
At $115M, American Healthcare REIT, Inc.'s cash & equivalents ranks #70 of 133 in the Real Estate sector. Cash & Equivalents returned to growth in FY2025 after 2 years of decline, reaching $115M.
Based on SEC 10-K filings.
$115M in FY2025 with a 5-year CAGR of +0.3%.
Improved from $82M to $115M over the past 2 years.
Real Estate sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +0.5%
- 5-Year CAGR
- +0.3%
- 10-Year CAGR
- -
Sector benchmark
#70 of 133 in Real EstateTop 53% of 133This company $114.8M Sector average $334.0M
▼
-65.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +0.3%, indicating consistent growth.
- In FY2025, cash & equivalents increased 49.7% year-over-year.
- Ranks #70 out of 133 companies in the Real Estate sector.
- Lowest cash & equivalents in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $114.8M | +49.7% |
| FY2024 | $76.7M | -6.0% |
| FY2023 | $81.6M | -27.9% |
| FY2022 | $113.2M | +38.7% |
| FY2021 | $81.6M | -27.9% |
| FY2020 | $113.2M | +113.0% |
| FY2019 | $53.1M | +51.3% |
| FY2018 | $35.1M | +395.7% |
| FY2017 | $7.1M | +216.8% |
| FY2016 | $2.2M | +1007.4% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026